SCHEMBL162537

SCHEMBL162537

CC(=S)SCc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.63
CA1 P00915 1/20 0.63
CA2 P00918 1/20 0.63
CA9 Q16790 1/20 0.63
IDO1 P14902 6/20 0.56
NOS1 P29475 2/20 0.56
NOS3 P29474 1/20 0.56
NOS2 P35228 1/20 0.56
TDP1 Q9NUW8 2/20 0.53
GAA P10253 1/20 0.53
TAAR1 Q96RJ0 1/20 0.53
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL560906 0.83 IDO1 (0.58) CA12CA1CA2CA9IDO1
SCHEMBL161188 0.83 CA12 (0.65) CA12CA1CA2CA9IDO1
SCHEMBL3461371 0.83 CA12 (0.65) CA12CA1CA2CA9IDO1
SCHEMBL10086570 0.82 IDO1 (0.59) CA12CA1CA2CA9IDO1
Hydrochloric Acid SCHEMBL11844622 0.81 CA12 (0.63) CA12CA1CA2CA9IDO1
SCHEMBL1140195 0.81 IDO1 (0.61) CA12CA1CA2CA9IDO1
SCHEMBL10821320 0.81 CA12 (0.63) CA12CA1CA2CA9IDO1
SCHEMBL23781322 0.80 CA12 (0.57) CA12CA1CA2CA9IDO1
SCHEMBL22652479 0.80 CA12 (0.57) CA12CA1CA2CA9IDO1
SCHEMBL12835101 0.80 IDO1 (0.57) CA12CA1CA2CA9IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1136521-B1 Process for preparing an ocular lens material having hydrophilic surface MENICON CO LTD (JP) 2007-02-21 EP claimed
US-6533415-B2 Ocular lens material having hydrophilic surface and process for preparing the same MENICON CO., LTD. (JP) 2003-03-18 US claimed
US-20010050749-A1 Ocular lens material having hydrophilic surface and process for preparing the same MENICON CO., LTD. (JP) 2001-12-13 US claimed
EP-1136521-A2 Ocular lens material having hydrophilic surface and process for preparing the same Menicon Co., Ltd. (JP) 2001-09-26 EP claimed
EP-4747339-A1 INDUSTRIAL GEAR LUBRICANT The Lubrizol Corporation (US) 2026-05-27 EP disclosed
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS BASF SE (DE) 2026-05-14 US disclosed
EP-4644354-A1 POLYMER MECHANORADICAL INITIATOR AND REACTION METHOD USING POLYMER MECHANORADICAL INITIATOR National University Corporation Hokkaido University (JP) 2025-11-05 EP disclosed
EP-2292668-B2 Process for preparing polymers and compositions thereof LUBRIZOL CORP (US) 2025-09-10 EP disclosed
US-20250269096-A1 FLUOROPOLYMER MEDICAL DEVICES UNOMEDICAL AS (DK) 2025-08-28 US disclosed
EP-4583934-A1 MEDICAL DEVICES Unomedical A/S (DK) 2025-07-16 EP disclosed
EP-4583933-A1 FLUOROPOLYMER MEDICAL DEVICES Unomedical A/S (DK) 2025-07-16 EP disclosed
US-20250195832-A1 MEDICAL DEVICES UNOMEDICAL AS (DK) 2025-06-19 US disclosed
WO-2006047398-A2 STAR POLYMERS AND COMPOSITIONS THEREOF THE LUBRIZOL CORPORATION (US) 2006-05-04 WO disclosed
US-20040171777-A1 Polymerization with living characteristics COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2004-09-02 US disclosed
US-6533415-B2 Ocular lens material having hydrophilic surface and process for preparing the same MENICON CO., LTD. (JP) 2003-03-18 US disclosed
US-20010050749-A1 Ocular lens material having hydrophilic surface and process for preparing the same MENICON CO., LTD. (JP) 2001-12-13 US disclosed
EP-0910587-B1 POLYMERIZATION WITH LIVING CHARACTERISTICS DU PONT (US) 2001-12-12 EP disclosed
EP-1136521-A2 Ocular lens material having hydrophilic surface and process for preparing the same Menicon Co., Ltd. (JP) 2001-09-26 EP disclosed
EP-0910587-A1 POLYMERIZATION WITH LIVING CHARACTERISTICS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1999-04-28 EP disclosed
WO-1998001478-A1 POLYMERIZATION WITH LIVING CHARACTERISTICS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS COPE, COPB2, C9 CA12 214/4885CA1 94/4885CA2 1824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.